Performance Characteristics of Current-Generation Immulite 2000 TORCH Assays | Zendy

Anna Rita Centonze | Zendy; Elisabetta Tonolli | Zendy; Roberta Fontana | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Performance Characteristics of Current-Generation Immulite 2000 TORCH Assays

Author(s) -

Anna Rita Centonze,

Elisabetta Tonolli,

Roberta Fontana

Publication year - 2012

Publication title -

clinical and vaccine immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.649

H-Index - 77

eISSN - 1556-6811

pISSN - 1556-679X

DOI - 10.1128/cvi.00106-12

Subject(s) - torch , cytomegalovirus , rubella virus , rubella , toxoplasma gondii , medicine , predictive value , herpes simplex virus , virology , toxoplasmosis , immunology , virus , herpesviridae , antibody , vaccination , materials science , viral disease , measles , welding , metallurgy

The performances of seven Immulite 2000 (Siemens Healthcare Diagnostics) TORCH (Toxoplasma gondii , other microorganisms, rubella virus, cytomegalovirus, and herpes simplex virus) assays were evaluated in comparison with the performances of the ETI-MAX 3000 (DiaSorin) TORCH assays. The two systems demonstrated good agreement, and given their sensitivity, specificity, and positive predictive value, they can be used with confidence for TORCH prenatal screening.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research